These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21742094)

  • 1. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    French JK; Armstrong PW; Cohen E; Kleiman NS; O'Connor CM; Hellkamp AS; Stebbins A; Holmes DR; Hochman JS; Granger CB; Mahaffey KW
    Am Heart J; 2011 Jul; 162(1):89-97. PubMed ID: 21742094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
    Stebbins A; Mehta RH; Armstrong PW; Lee KL; Hamm C; Van de Werf F; James S; Toftegaard-Nielsen T; Seabra-Gomes R; White HD; Granger CB;
    Circ Cardiovasc Interv; 2010 Oct; 3(5):414-22. PubMed ID: 20858863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Alhadramy O; Westerhout CM; Brener SJ; Granger CB; Armstrong PW;
    Am Heart J; 2010 May; 159(5):899-904. PubMed ID: 20435202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
    ; Armstrong PW; Granger CB; Adams PX; Hamm C; Holmes D; O'Neill WW; Todaro TG; Vahanian A; Van de Werf F
    JAMA; 2007 Jan; 297(1):43-51. PubMed ID: 17200474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Armstrong PW; Adams PX; Al-Khalidi HR; Hamm C; Holmes D; O'Neill W; Todaro TG; Vahanian A; Van de Werf F; Granger CB;
    Am Heart J; 2005 Mar; 149(3):402-7. PubMed ID: 15864228
    [No Abstract]   [Full Text] [Related]  

  • 7. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
    Toma M; Fu Y; Ezekowitz JA; McAlister FA; Westerhout CM; Granger CB; Armstrong PW
    Am Heart J; 2010 Oct; 160(4):671-7. PubMed ID: 20934561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
    Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
    Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
    Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observation of short- and mid-term clinical outcome of percutaneous coronary intervention for acute myocardial infarction with heart failure or cardiogenic shock].
    Wang TH; Liu YF; Li ZL; Wei XL; Shi XD
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1064-6. PubMed ID: 16109580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.
    Garot P; Bendaoud N; Lefèvre T; Morice MC
    EuroIntervention; 2010 Aug; 6(3):350-5. PubMed ID: 20884413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW;
    Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Hudson MP; Armstrong PW; O'Neil WW; Stebbins AL; Weaver WD; Widimsky P; Aylward PE; Ruzyllo W; Holmes D; Mahaffey KW; Granger CB
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):183-92. PubMed ID: 21304097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary percutaneous coronary intervention in patients admitted with cardiogenic shock and ST-elevation myocardial infarction: prognosis and predictors of in-hospital mortality].
    Ergelen M; Uyarel H; Akkaya E; Yıldırım E; Ersan D; Demirci D; Türkkan C; Sayar N; Akyüz S; Tezel T
    Turk Kardiyol Dern Ars; 2010 Jun; 38(4):250-7. PubMed ID: 20935431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.
    Tjandrawidjaja MC; Fu Y; Westerhout CM; White HD; Todaro TG; Van de Werf F; Mahaffey KW; Wagner GS; Granger CB; Armstrong PW;
    Eur Heart J; 2010 Mar; 31(5):573-81. PubMed ID: 19952006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shock index: a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction.
    Bilkova D; Motovska Z; Widimsky P; Dvorak J; Lisa L; Budesinsky T
    Can J Cardiol; 2011; 27(6):739-42. PubMed ID: 21944278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Kaul P; Fu Y; Westerhout CM; Granger CB; Armstrong PW
    Am J Cardiol; 2012 Dec; 110(11):1555-60. PubMed ID: 22920928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Trendelenburg M; Theroux P; Stebbins A; Granger C; Armstrong P; Pfisterer M
    Eur Heart J; 2010 May; 31(10):1181-7. PubMed ID: 20089518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    Shavadia J; Zheng Y; Dianati Maleki N; Huber K; Halvorsen S; Goldstein P; Gershlick AH; Wilcox R; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2015 Aug; 4(8):e002049. PubMed ID: 26304934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.